A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Clinical trial NCT00569582 · COMPLETED

Trial details

NCT number: NCT00569582
Sponsor: Corcept Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cushing's Syndrome

Start date: 2007-12-01
Primary completion: 2011-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.